English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Vifor Pharma
Press release submission
| Dec 10, 2021
First patient enrolled in phase-IIa study of vamifeport in patients with sickle cell disease
Nicholas Gueguen
| Aug 13, 2017
Vifor Pharma begins new tests of Ferinject in patients with heart failure, iron deficiency
Robert Hadley
| Apr 28, 2017
Vifor Pharma offers grants aimed at combating iron deficiency
Gene Johnson
| Mar 1, 2017
Vifor buys rights to sell renal treatment in most of Asia
Carol Ostrow
| Feb 16, 2017
Swiss company holds iron deficiency to the fire
Keri Carbaugh
| Jan 6, 2017
Kidney Health Alliance expands to include CCX140
Amanda Rupp
| Jun 11, 2016
Vifor Pharma grants Pfizer commercialization rights
Amanda Rupp
| May 25, 2016
Vifor Pharma buys rights to rare renal disease treatment
Trending
Patient Daily
| Aug 18, 2025
Medfluence Advisors’ Greg Caesar to open ASCENT 2025 with keynote on digital practice growth
Patient Daily
| Aug 21, 2025
SoCal Breathe Free doctor on balloon sinuplasty: ‘The procedure itself is pretty quick and effectiveness is pretty high’
Patient Daily
| Aug 21, 2025
Otolaryngologist on sinusitis and tooth pain: ‘Inflammation in the bottom of the sinus can cause sensitivity in the teeth’
+
Pharmaceuticals
Patient Daily
| Aug 21, 2025
PhRMA director of public affairs on 340B rebate model: "Positive first step toward addressing hospital abuse of the 340B program
